who reports todayUS earnings, drawn as flowsMy portfolio

← Who reports today · Health Care

CI · Q2 2026

Archived report (Q2 2026). Latest deep dive →

US GAAP, Q2 2026 · released Jul 30

Shareholders' Net Income

$1,660M

up 8.4% y/y

Total Revenues

$71,668M

up 6.7% y/y

The quarter in brief

A huge-flow, thin-margin quarter working as designed — revenues +7% to $71.7B (pharmacy alone $57.2B), shareholders' net income +8% to $1,660M at a 2.3% net margin; the insurance side (Cigna Healthcare, adjusted pre-tax +17%) did the growing while Evernorth pharmacy profit was flat, and the FY adjusted-EPS outlook was raised to ≥$30.45.

All figures in $M.

Sankey diagram of CI earnings report for Q2 2026: revenue, costs and profitPharmacy Revenues$57,172 · +6.6%Premiums$9,859 · +7.7%Fees & Other$4,365 · +5.5%Net Investment Income$272 · +15.3%Total Revenues$71,668 · +6.7%Pharmacy, Medical& Operating Costs ≈$69,49897% of revenues — thepass-through riverPretax Income ≈$2,170Income Taxes ≈$510Shareholders' Net Income$1,660 · +8.4%2.3% margin · EPS $6.29
Sankey diagram of CI earnings report for Q2 2026: revenue, costs and profit
Line itemAmount and change
Pharmacy Revenues$57,172 · +6.6%
Premiums$9,859 · +7.7%
Fees & Other$4,365 · +5.5%
Net Investment Income$272 · +15.3%
Total Revenues$71,668 · +6.7%
Pharmacy, Medical & Operating Costs ≈$69,498 · 97% of revenues — the pass-through river
Pretax Income ≈$2,170
Income Taxes ≈$510
Shareholders' Net Income$1,660 · +8.4% · 2.3% margin · EPS $6.29

Verdict: a huge-flow, thin-margin quarter working as designed — revenues +7% to $71.7B (pharmacy alone $57.2B), shareholders' net income +8% to $1,660M at a 2.3% net margin; the insurance side (Cigna Healthcare, adjusted pre-tax +17%) did the growing while Evernorth pharmacy profit was flat, and the FY adjusted-EPS outlook was raised to ≥$30.45.

Adjusted income from operations $2.05B ($7.78/share, +9%). Shareholders' equity $161.35/share (+7%). Weighted shares 264M (−1.6% y/y).

Source and notation

≈ marks derived lines: the release discloses revenues and segment adjusted pre-tax income; the full expense statement lives in the 10-Q. Source: Cigna press release 8-K EX-99.1 (SEC EDGAR).

Open as an image: CI, Q2 2026 (PNG) ↗ · for sharing and presentations · free to reuse, CC BY 4.0

Cite / embed this chart

Free to use in articles, research and social posts with credit to Who Reports Today and a link — licensed under CC BY 4.0 (terms).

Credit line
Chart: “CI Q2 2026: where the revenue went” by Who Reports Today, https://whoreportstoday.com/t/ci/q2-2026. Licensed under CC BY 4.0.
HTML: image with link and credit
<figure>
  <a href="https://whoreportstoday.com/t/ci/q2-2026"><img src="https://whoreportstoday.com/t/ci/q2-2026/sankey.png" alt="CI Q2 2026: where the revenue went" loading="lazy" style="max-width:100%;height:auto"></a>
  <figcaption>Source: <a href="https://whoreportstoday.com/t/ci/q2-2026">Who Reports Today</a>, licensed under <a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a></figcaption>
</figure>
Direct link to the image (PNG)
https://whoreportstoday.com/t/ci/q2-2026/sankey.png
Link for your article text
<a href="https://whoreportstoday.com/t/ci/q2-2026">CI Q2 2026 earnings chart (Who Reports Today)</a>

This is an archived report: the image at this link won’t change. If you change the chart (crop, translate), say so in the credit. Company logos and trademarks are not covered by the license.

CI — CI is a US-based financial services company offering asset management, wealth management, and investment products.

It serves individual and institutional clients through a network of advisors and distribution partners across North America.

More reports: CNC · Q3 2026 · COO · Q3 FY2026 · COR · Q4 FY2026 · CRL · Q3 2026 · CVS · Q3 2026 · DGX · Q3 2026 · DHR · Q3 2026 · DVA · Q3 2026 · DXCM · Q3 2026 · ELV · Q3 2026 · all reports

Company reports

Q3 2026latest breakdownTotal revenues rose 6% year over year to $73.7 billion in Q3 2026, while shareholders' net income fell to $1.4 billion…
Q2 2026A huge-flow, thin-margin quarter working as designed — revenues +7% to $71.7B (pharmacy alone $57.2B), shareholders' net…

Cookies the site needs and, with your consent, Google Analytics — privacy policy